Exxon Mobil Corporation (XOM) Releases Second-Quarter 2025 Results

Drawing significant hedge fund interest, Exxon Mobil Corporation (NYSE:XOM) secures a spot on our list of the 13 Best Oil Refinery Stocks to Buy Right Now.

Exxon Mobil Corporation (NYSE:XOM) released Q2 2025 earnings on August 1, 2025. The company reported earnings of $7.1 billion and cash flow from operations of $11.5 billion, amid challenging market conditions. At the same time, $9.2 billion was distributed among shareholders, including $5 billion in buybacks and $4.3 billion in dividends. This is in line with the company’s plan to return $20 billion through repurchases in 2025. Furthermore, XOM has already repurchased 40% of the shares issued for the Pioneer acquisition since May 2024.

Moreover, Exxon Mobil Corporation (NYSE:XOM) recorded its highest Q2 upstream production, thanks to record Permian output and volume growth in Guyana. Meanwhile, Singapore Resid Upgrade, Fawley refinery, and Strathcona Renewable Diesel projects bolstered its high-value product portfolio. These projects are expected to generate $3 billion in earnings by 2026.

Exxon Mobil Corporation (NYSE:XOM)’s year-to-date operating cash flow reached $24.5 billion, while its free cash flow reached $14.2 billion. The company maintained a robust net-debt-to-capital ratio of 8% with a YTD capital spending of $12.3 billion. Full-year spending guidance remains at $27-29 billion.

Exxon Mobil Corporation (NYSE:XOM) is focused on the production, refining, and sale of oil, gas, chemicals, and specialty products globally.

While we acknowledge the potential of XOM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Cheap Value Stocks to Buy Now According to Warren Buffett and 7 Best Potash Stocks to Buy According to Analysts.

Disclosure: None.